dailypolitical.com
Neutralwww.dailypolitical.com ·
gt biopharma nasdaqgtbp posts quarterly earnings results
WB_698_TRADETAX_FNCACT_KILLERTAX_FNCACT_ANALYSTTAX_FNCACT_RESEARCH_ANALYST
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedGT Biopharma, a small-cap biotech, missed earnings estimates, causing a minor stock decline. The company is pre-revenue with no approved products; the earnings miss does not affect any product/commodity price, supply chain, or margins of other firms. Impact is single-company-specific and weak.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- GT Biopharma reported Q earnings loss of $0.11 per share, missing consensus estimate of $0.08.
- Stock fell $0.05 to $0.39 on trading day after announcement.
- Market cap is $14.03 million.
- Lead candidate GTB-3550 for hematologic malignancies.
- Weiss Ratings reiterated 'sell (e+)' rating.
Related stories
finance.yahoo.com
kevin warsh confirmed fed chair 222854400
finance.yahoo.com
ncmi q1 2026 earnings transcript 154748256
finance.yahoo.com
aii q1 2026 earnings transcript 193721515
economictimes.indiatimes.com
missiles over dubai rattle the gulfs billion dollar money machine dubai property uae deal ipo market
finance.yahoo.com